Cross Country Healthcare, Inc. (Nasdaq: CCRN) today reported
revenue of $113.7 million in the fourth quarter ended December 31,
2010 and a net loss of $6.0 million, or ($0.19) per diluted share.
Adjusted net income, a non-GAAP financial measure as defined in the
accompanying financial statement tables, was $0.6 million, or $0.02
per diluted share on an adjusted basis, and excluded $6.6 million
of after-tax trademark impairment charges related to the Medical
Doctor Associates acquisition. In the same quarter of the prior
year, the Company had revenue of $124.1 million and net income of
$0.4 million, or $0.01 per diluted share. Adjusted net income was
$1.7 million, or $0.05 per diluted share on an adjusted basis, and
excluded an impairment charge and a legal settlement charge
totaling $1.3 million after-tax. Cash flow from operations for the
fourth quarter of 2010 was $6.7 million.
For the year ended December 31, 2010, the Company generated
revenue of $468.6 million and had a net loss of $2.8 million, or
($0.09) per diluted share. Adjusted net income was $3.8 million, or
$0.12 per diluted share on an adjusted basis. This compares to
revenue of $578.2 million and net income of $6.7 million, or $0.22
per diluted share in the prior year. Adjusted net income in the
prior year was $8.0 million, or $0.26 per diluted share on an
adjusted basis. Cash flow from operations for the year ended
December 31, 2010 was $31.5 million.
“The fourth quarter of 2010 appears to be the nadir of the most
challenging period in our Company’s history as our revenue
expectation is for solid sequential growth in the first quarter of
2011,” said Joseph A. Boshart, President and Chief Executive
Officer of Cross Country Healthcare, Inc. “I continue to believe
our strategy and operating discipline has put us in an attractive
position relative to our major competitors. In particular, our
early and internally-developed entry in 2003 into the managed
service provider (MSP) delivery model has paid significant
dividends for us, especially during this recent demand constrained
environment,” he added.
Mr. Boshart continued, “In our nurse and allied staffing
business, demand for travel nurses is currently running at more
than double the level of a year ago, although it remains well below
historical levels. Our expectation for revenue improvement is being
driven largely by our best-in-class MSP solution, which currently
accounts for approximately 30% of our nurse and allied FTEs.
Moreover, the number of hospitals where we have been awarded MSP
status but have not yet implemented our program gives us confidence
that our momentum is sustainable. We are also encouraged by the
growth taking place in our clinical trial services business, which
is the result of solid performance in the staffing component of
this business. Meanwhile, in our physician staffing business, so
far this year we have seen more positive indicators, but we remain
only cautiously optimistic, in part, because of the limited
visibility in this segment.”
Nurse and Allied Staffing
For the fourth quarter of 2010, the nurse and allied staffing
business segment (travel and per diem nurse and allied health
staffing) generated revenue of $59.4 million, reflecting a 2%
sequential increase from the third quarter of 2010, but a 9%
decrease from the prior year quarter of $65.4 million. The
sequential increase was due to higher FTE staffing volume.
Contribution income (defined as income from operations before
depreciation, amortization, impairment charges and corporate
expenses not specifically identified to a reporting segment)
increased 6% sequentially due to higher revenue and lower workers’
compensation expenses, but decreased 22% to $5.6 million in the
fourth quarter of 2010 from $7.2 million in the same quarter a year
ago due to lower operating leverage.
Segment staffing volume increased 2% sequentially from the third
quarter of 2010, but decreased 8% from the prior year quarter.
Travel staffing volume increased 3% on a sequential basis, but
decreased 8% on a year-over-year basis. The segment revenue per FTE
per day for the fourth quarter of 2010 was $304, essentially
unchanged sequentially and down 1% on a year-over-year basis. For
travel nurse staffing the average hourly bill rate decreased 1%
sequentially and 3% year-over-year.
For the year-ended December 31, 2010, segment revenue decreased
23% to $242.2 million from $313.0 million in the prior year.
Contribution income decreased 25% to $22.9 million from $30.6
million in the prior year.
Physician Staffing
For the fourth quarter of 2010, the physician staffing business
segment generated revenue of $27.9 million, an 11% decrease
sequentially from the third quarter of 2010 and a 16% decrease from
$33.3 million in the prior year quarter reflecting a decline in
demand and change in mix of physician specialties. Contribution
income decreased 16% sequentially due to a decline in revenue that
was partially offset by lower professional liability expenses and
decreased 23% year-over-year due to lower operating leverage.
Physician staffing days filled for the fourth quarter of 2010 was
17,924 days, an 11% decrease sequentially and an 18% decrease from
the prior year quarter. Revenue per day filled for the fourth
quarter of 2010 was $1,556, up fractionally on a sequential basis
and a 2% increase from the prior year quarter due to a change in
the mix of specialties.
For the year-ended December 31, 2010, segment revenue decreased
20% to $121.6 million from $151.9 million in the prior year.
Contribution income decreased 14% to $13.1 million from $15.2
million in the prior year.
The Company believes the lingering effects of the recession and
the weak housing market continue to delay the retirement plans of
many physicians. These factors, along with a trend in which
hospitals have had increased success in directly hiring physicians,
have resulted in a decrease in demand for temporary physicians.
Clinical Trial Services
For the fourth quarter of 2010, the clinical trial services
segment generated revenue of $15.3 million, a 2% decrease
sequentially from the third quarter of 2010 and a 3% increase from
$14.9 million in the prior year quarter. The sequential decrease
was due to three less billable days, while the year-over-year
increase was due to a higher average contract bill rate in the
staffing business, which accounted for more than 90% of segment
revenue. Contribution income was $1.3 million, a decrease of 25%
sequentially due to the aforementioned fewer billable days and
weakness in the non-staffing components of this segment, but a 46%
increase on a year-over-year basis due primarily to significantly
lower SG&A expenses in the fourth quarter of 2010.
For the year-ended December 31, 2010, segment revenue decreased
14% to $62.0 million from $71.7 million in the prior year.
Contribution income decreased 9% to $6.4 million from $7.0 million
in the prior year.
Other Human Capital Management Services
For the fourth quarter of 2010, the other human capital
management services business segment (education and training and
retained search) generated revenue of $11.1 million, a 6% increase
sequentially from the third quarter of 2010 and a 4% increase from
revenue of $10.7 million in the prior year quarter. Segment
contribution income increased 90% sequentially and increased 24%
from the prior year quarter to $1.3 million in the fourth quarter
of 2010 due to improvements in both the education and the retained
search businesses.
For the year-ended December 31, 2010, segment revenue increased
3% on a year-over-year basis to $42.8 million from $41.7 million in
the prior year. Contribution income increased 27% to $3.8 million
from $3.0 million in the prior year.
Debt Outstanding and Credit Facility
During the fourth quarter of 2010, the Company reduced its debt
by $1.6 million from the end of the prior quarter. At December 31,
2010, the Company had $53.5 million of total debt on its balance
sheet and a debt, net of cash, to total capitalization ratio of
14.2%. At the end of the fourth quarter of 2010, the Company’s debt
leverage ratio (as defined in its credit agreement) was 2.1 to 1,
below the 2.5 to 1 maximum allowable ratio effective for the
duration of the credit agreement. Non-cash impairment charges have
no impact on the Company’s debt covenant calculation.
Guidance for First Quarter 2011
The following statements are based on current management
expectations. Such statements are forward-looking and actual
results may differ materially. These statements do not include the
potential impact of any future mergers, acquisitions or other
business combinations, any impairment charges or valuation
allowances, any significant legal proceedings or repurchases of the
Company's common stock.
For the first quarter of 2011, the Company expects:
- Revenue to be in the $119.0 million to
$121.0 million range.
- Gross profit margin to be in the range
of 26.5% to 27.0%.
- Adjusted EBITDA to be in the 3.5% to
4.5% range. Adjusted EBITDA, a non-GAAP financial measure, is
defined in the accompanying financial statement tables.
- Earnings per diluted share to be in the
range of $0.00 to $0.02. The preceding EPS guidance is based on an
estimated effective tax rate of 50%. Historically, the Company’s
gross profit margin declines sequentially from the fourth quarter
to the first quarter due to factors such as the reset of payroll
taxes, as well as two less days in the first quarter of the year.
This combination results in a sequential decrease in earnings
estimated at approximately $0.04 per diluted share in the first
quarter.
Quarterly Conference Call
Cross Country Healthcare will hold a conference call on
Wednesday, March 9th at 10:00 a.m. Eastern Time to discuss its
fourth quarter and year-end 2010 financial results. This call will
be webcast live and may be accessed at the Company’s website at
www.crosscountryhealthcare.com or by dialing 888-972-6408 from
anywhere in the U.S. or by dialing 210-234-0087 from non-U.S.
locations – Passcode: Cross Country. A replay of the webcast will
be available from March 9th through March 23rd. A replay of the
conference call will be available by telephone from approximately
noon Eastern Time on March 9th until March 23rd by calling
800-666-8984 from anywhere in the U.S. or 402-220-0269 from
non-U.S. locations – Passcode: 2010.
Non-GAAP (Generally Accepted Accounting Principles) Financial
Measures
This press release and accompanying financial statement tables
reference non-GAAP financial measures including non-GAAP adjusted
EBITDA, non-GAAP adjusted net income and non-GAAP adjusted earnings
per diluted share. These non-GAAP financial measures are provided
as additional information and should not be considered substitutes
for, or superior to, financial measures calculated in accordance
with U.S. GAAP. These non-GAAP financial measures are provided for
consistency and comparability to prior year results; furthermore,
management believes they are useful to investors when evaluating
the Company’s performance as it excludes certain items that
management believes are not indicative of the Company’s operating
performance. These non-GAAP financial measures may differ
materially from the non-GAAP financial measures used by other
companies. The financial statement tables that accompany this press
release include a reconciliation of each non-GAAP financial measure
to the most directly comparable U.S. GAAP financial measure and a
more detailed discussion of each financial measure; as such, the
financial statement tables should be read in conjunction with the
presentation of these non-GAAP financial measures.
Correction for Barclays Capital Global Healthcare Conference
Presentation
The following corrects certain information in the Company’s
previously issued press release on March 3, 2011: Cross Country
Healthcare, Inc. is scheduled to make a presentation on Tuesday,
March 15, 2011, at 2:00 p.m. Eastern Time at the Barclays Capital
Global Healthcare Conference being held at the Lowes Miami Beach
Hotel in Miami Beach, Florida.
About Cross Country Healthcare
Cross Country Healthcare, Inc. is a diversified leader in
healthcare staffing services offering a comprehensive suite of
staffing and outsourcing services to the healthcare market that
include nurse and allied staffing, physician staffing, clinical
trial services and other human capital management services. The
Company believes it is one of the top two providers of travel nurse
and allied staffing services; one of the top three providers of
temporary physician staffing (locum tenens) services; a leading
provider of clinical trials staffing services and retained
physician search services; and a provider of educational seminars,
specifically for the healthcare marketplace. On a company-wide
basis, Cross Country Healthcare has approximately 4,500 contracts
with hospitals and healthcare facilities, pharmaceutical and
biotechnology customers, and other healthcare organizations to
provide our healthcare staffing and outsourcing solutions. Copies
of this and other news releases as well as additional information
about Cross Country Healthcare can be obtained online at
www.crosscountryhealthcare.com. Shareholders and prospective
investors can also register at this website to automatically
receive the Company's press releases, SEC filings and other notices
by e-mail.
In addition to historical information, this press release
contains statements relating to our future results (including
certain projections and business trends) that are “forward-looking
statements” within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”),
and are subject to the “safe harbor” created by those sections.
Forward-looking statements consist of statements that are
predictive in nature, depend upon or refer to future events. Words
such as “expects”, “anticipates”, “intends”, “plans”, “believes”,
“estimates”, “suggests”, “appears”, “seeks”, “will” and variations
of such words and similar expressions intended to identify
forward-looking statements. Forward-looking statements involve
known and unknown risks, uncertainties and other factors that may
cause our actual results and performance to be materially different
from any future results or performance expressed or implied by
these forward-looking statements. These factors include, without
limitation, the following: our ability to attract and retain
qualified nurses, physicians and other healthcare personnel, costs
and availability of short-term housing for our travel nurses and
physicians, demand for the healthcare services we provide, both
nationally and in the regions in which we operate, the functioning
of our information systems, the effect of existing or future
government regulation and federal and state legislative and
enforcement initiatives on our business, our clients’ ability to
pay us for our services, our ability to successfully implement our
acquisition and development strategies, the effect of liabilities
and other claims asserted against us, the effect of competition in
the markets we serve, our ability to successfully defend the
Company, its subsidiaries, and its officers and directors on the
merits of any lawsuit or determine its potential liability, if any,
and other factors set forth in Item 1A. “Risk Factors” in the
Company’s Annual Report on Form 10-K for the year ended
December 31, 2009, and our other Securities and Exchange
Commission filings made during 2010 and 2011.
Although we believe that these statements are based upon
reasonable assumptions, we cannot guarantee future results and
readers are cautioned not to place undue reliance on these
forward-looking statements, which reflect management’s opinions
only as of the date of this press release. There can be no
assurance that (i) we have correctly measured or identified
all of the factors affecting our business or the extent of these
factors’ likely impact, (ii) the available information with
respect to these factors on which such analysis is based is
complete or accurate, (iii) such analysis is correct or
(iv) our strategy, which is based in part on this analysis,
will be successful. The Company undertakes no obligation to update
or revise forward-looking statements. All references to “we,” “us,”
“our,” or “Cross Country” in this press release mean Cross Country
Healthcare, Inc., its subsidiaries and affiliates.
Cross Country Healthcare, Inc.
Consolidated Statements of Operations
(a)
(Unaudited, amounts in thousands,
except per share data)
Three Months Ended Year Ended December
31, December 31, 2010 2009
% Change
2010 2009
% Change
Revenue from services $ 113,677 $ 124,139
(8%)
$ 468,562 $ 578,237
(19%)
Operating expenses: Direct operating expenses 81,079 88,997
(9%)
336,250 424,984
(21%)
Selling, general and administrative expenses 27,147 27,462
(1%)
108,984 120,690
(10%)
Bad debt expense 179 227
(21%)
294 -
ND
Depreciation 1,887 2,128
(11%)
8,043 8,773
(8%)
Amortization 964 972
(1%)
3,851 4,018
(4%)
Impairment charges (b) 10,764 1,726
524%
10,764 1,726
524%
Legal settlement charge (c) - 345
(100%)
- 345
(100%)
Total operating expenses 122,020 121,857
0%
468,186 560,536
(16%)
(Loss) income from operations (8,343 ) 2,282
NM
376 17,701
(98%)
Other expenses (income):
Foreign exchange loss
4 35
(89%)
76 66
15%
Interest expense, net 755 1,296
(42%)
4,072 6,174
(34%)
Other income - -
-
- (193 )
100%
(Loss) income before income taxes (9,102 ) 951
NM
(3,772 ) 11,654
NM
Income tax (benefit) expense (3,098 ) 553
NM
(997 ) 4,960
NM
Net (loss) income $ (6,004 ) $ 398
NM
$ (2,775 ) $ 6,694
NM
Net (loss) income per common share: Basic $ (0.19 ) $ 0.01
NM
$ (0.09 ) $ 0.22
NM
Diluted $ (0.19 ) $ 0.01
NM
$ (0.09 ) $ 0.22
NM
Weighted average common shares outstanding: Basic 31,103
30,917 31,060 30,825 Diluted 31,103 31,108 31,060 30,999
Cross Country Healthcare, Inc. Reconciliation of
Non-GAAP Financial Measures
Adjusted EBITDA, Adjusted Pretax
Income, Adjusted Net Income and Adjusted Earnings Per Diluted
Share
(Unaudited, amounts in thousands, except per share data)
Three Months Ended Year Ended December
31, December 31, 2010 2009 2010
2009 (Loss) income from operations $ (8,343 ) $ 2,282 $ 376
$ 17,701 Depreciation 1,887 2,128 8,043 8,773 Amortization 964 972
3,851 4,018 Impairment charges (b) 10,764 1,726 10,764 1,726 Legal
settlement charge (c) - 345 - 345 Equity compensation 715
599 2,657 1,963
Adjusted EBITDA (d) $ 5,987 $ 8,052 $ 25,691 $
34,526 Net (loss) income $ (6,004 ) $ 398 $ (2,775 )
$ 6,694 Impairment charges (b) 10,764 1,726 10,764 1,726 Legal
settlement charge (c) - 345 -
345 Adjusted pretax income (e) 4,760 2,469
7,989 8,765 Tax effect of impairment charges (4,164 ) (673 ) (4,164
) (673 ) Tax effect of legal settlement charge -
(136 ) - (136 ) Adjusted net income (e)
$ 596 $ 1,660 $ 3,825 $ 7,956
Net (loss) income per common share - diluted $ (0.19 ) $
0.01 $ (0.09 ) $ 0.22 Impairment charges per diluted share 0.35
0.05 0.35 0.05 Legal settlement charge per diluted share -
0.01 - 0.01
Adjusted pretax income per diluted share 0.16 0.07 0.26 0.28 Tax
effect of impairment charges per diluted share (0.14 ) (0.02 )
(0.14 ) (0.02 ) Tax effect of legal settlement charge per diluted
share - (0.00 ) - (0.00 )
Adjusted earnings per diluted share (e) $ 0.02 $ 0.05
$ 0.12 $ 0.26
Weighted average common shares outstanding
used in the calculation of non-GAAP Adjusted earnings per diluted
share
31,151 31,108 31,160 30,999
Cross Country
Healthcare, Inc. Condensed Consolidated Balance Sheets
(Unaudited, amounts in thousands) December 31,
December 31, 2010 2009 Assets Current
assets: Cash and cash equivalents $ 10,957 $ 6,861 Short-term cash
investments 1,870 1,708 Accounts receivable, net 64,395 70,172
Deferred tax assets 11,801 11,794 Income taxes receivable 5,595
7,405 Other current assets 9,796 7,794
Total current assets 104,414 105,734 Property and equipment, net
14,536 19,706 Trademarks, net 52,055 62,858 Goodwill, net 143,349
130,701 Other identifiable intangible assets, net 24,681 28,572
Debt issuance costs, net 2,112 1,536 Non-current deferred tax
assets 2,484 5,390 Other long-term assets 4,577
2,092 Total assets $ 348,208 $ 356,589
Liabilities and Stockholders' Equity Current
liabilities: Accounts payable and accrued expenses $ 7,944 $ 8,143
Accrued employee compensation and benefits 17,258 16,140 Current
portion of long-term debt 7,957 5,733 Interest rate swaps - current
- 1,427 Other current liabilities 3,744 3,113
Total current liabilities 36,903 34,556 Long-term
debt 45,556 56,781 Other long-term liabilities 19,740
19,181 Total liabilities 102,199 110,518
Commitments and contingencies Stockholders' equity: Common
stock 3 3 Additional paid-in capital 243,005 240,870 Other
comprehensive income (2,401 ) (2,979 ) Retained earnings
5,402 8,177 Total stockholders' equity 246,009
246,071 Total liabilities and stockholders' equity $
348,208 $ 356,589
Cross Country Healthcare,
Inc. Segment Data (f) (Unaudited, amounts in
thousands) Three Months Ended Year Ended
December 31, December 31, 2010
% ofTotal
2009
% ofTotal
% Change 2010
% ofTotal
2009
% ofTotal
% Change Revenue: Nurse and allied staffing $
59,417 52% $ 65,374 53% (9%) $ 242,160 52% $ 313,038 54% (23%)
Physician staffing 27,895 25% 33,253 27% (16%) 121,599 26% 151,853
26% (20%) Clinical trial services 15,301 13% 14,862 12% 3% 61,957
13% 71,678 13% (14%) Other human capital management services
11,064 10% 10,650 8% 4% 42,846
9% 41,668 7% 3% $ 113,677 100% $ 124,139
100% (8%) $ 468,562 100% $ 578,237 100% (19%)
Contribution income (g) Nurse and allied staffing $
5,623 $ 7,175 (22%) $ 22,888 $ 30,641 (25%) Physician staffing
2,958 3,831 (23%) 13,052 15,165 (14%) Clinical trial services 1,336
918 46% 6,391 7,029 (9%) Other human capital management services
1,279 1,033 24% 3,768
2,973 27% 11,196 12,957 (14%) 46,099 55,808 (17%)
Unallocated corporate overhead 5,924 5,504 8% 23,065 23,245 (1%)
Depreciation 1,887 2,128 (11%) 8,043 8,773 (8%) Amortization 964
972 (1%) 3,851 4,018 (4%) Impairment charges 10,764 1,726 524%
10,764 1,726 524% Legal settlement charge -
345 (100%) - 345 (100%) (Loss)
income from operations $ (8,343 ) $ 2,282 NM $ 376 $
17,701 (98%)
Cross Country Healthcare,
Inc. Other Financial Data (Unaudited)
Three Months Ended Year Ended December 31,
December 31, 2010 2009 2010 2009
Net cash provided by operating activities (in thousands) (a) $
6,737 $ 2,476 $ 31,522 $ 72,400
Nurse and allied
staffing statistical data: FTEs (h) 2,124 2,314 2,185 2,735
Days worked (i) 195,408 212,888 797,525 998,275 Average nurse and
allied staffing revenue per FTE per day (j) $ 304 $ 307 $ 304 $ 314
Physician staffing statistical data: Days
filled (k) 17,924 21,851 78,346 95,253 Revenue per day filled (l) $
1,556 $ 1,522 $ 1,552 $ 1,594 (a) Prior year data has been
reclassified to conform to the current year's presentation. (b)
Impairment charges in the three months and year ended December 31,
2010, relate to the impairment of trademarks acquired in the
Company's MDA acquisition, of which $10.0 million was for a
trademark in the Company's physician staffing business segment and
$0.7 million was for a trademark in the Company's nurse and allied
staffing business segment. Impairment charges in the three months
and year ended December 31, 2009 relate to an impairment of a
specific trademark and database in the Company's clinical trial
services business segment. (c) Legal settlement charge relates to
an agreement to settle a class action lawsuit (Maureen Petray and
Carina Higareda v. MedStaff, Inc.). (d) Adjusted EBITDA, a non-GAAP
(Generally Accepted Accounting Principles) financial measure, is
defined as (loss) income from operations before depreciation,
amortization, non-cash impairment charges, a legal settlement
charge related to a class action lawsuit (named above), and
non-cash equity compensation. Adjusted EBITDA should not be
considered a measure of financial performance under GAAP.
Management presents Adjusted EBITDA because it believes that
Adjusted EBITDA is a useful supplement to (loss) income from
operations as an indicator of operating performance. Management
uses Adjusted EBITDA as one performance measure in its annual cash
incentive program for certain members of its management team. In
addition, management monitors Adjusted EBITDA for planning
purposes, including compliance with its debt covenants. Adjusted
EBITDA, as defined, closely matches the operating measure used in
the Company's Debt Leverage Ratio and Minimum Fixed Charges Ratio
as defined by its Credit Agreement. Management believes Adjusted
EBITDA, as defined, is useful to investors when evaluating the
Company's performance as it excludes certain items that management
believes are not indicative of the Company's operating performance.
(e) Adjusted pretax income, Adjusted net income and Adjusted
earnings per diluted share, non-GAAP financial measures, are
defined by pretax income, net income and earnings per diluted share
before the non-cash impairment charges and a legal settlement
charge related to a class action lawsuit (see footnote c above).
Adjusted pretax income, Adjusted net income and Adjusted earnings
per diluted share should not be considered a measure of financial
performance under GAAP and have been provided for consistency and
comparability of the 2010 results with the prior periods.
Management believes such a measure provides a picture of the
Company's results that is more comparable among periods since it
excludes the impact of items that may recur occasionally, but tend
to be irregular as to timing, thereby distorting comparisons
between periods. (f) Segment data provided is in accordance with
the Segment Reporting Topic of the FASB ASC. (g) Defined as income
from operations before depreciation, amortization, impairment
charges and corporate expenses not specifically identified to a
reporting segment. Contribution income is a financial measure used
by management when assessing segment performance. (h) FTEs
represent the average number of nurse and allied contract staffing
personnel on a full-time equivalent basis. (i) Days worked is
calculated by multiplying the FTEs by the number of days during the
respective period. (j) Average revenue per FTE per day is
calculated by dividing the nurse and allied staffing revenue by the
number of days worked in the respective periods. Nurse and allied
staffing revenue also includes revenue from permanent placement of
nurses. (k) Days filled is calculated by dividing the total hours
filled during the period by 8 hours. (l) Revenue per day filled is
calculated by dividing the applicable revenue generated by the
Company's physician staffing segment by days filled for the period
presented. ND - Not determinable NM - Not meaningful
Cross Country Health (NASDAQ:CCRN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cross Country Health (NASDAQ:CCRN)
Historical Stock Chart
From Sep 2023 to Sep 2024